Lauren Lutz, NP
Psychiatric/Mental Health · Columbus, INNPI 1417407743
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $262,886 of the $319,934 with a category attached, or 82.2%. 28 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 40.7% of the total. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 967 payments — averaging $330.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$130K
- AbbVie$69K
- Axsome Therapeutics, Inc.$42K
- Neurocrine Biosciences, Inc.$29K
- Alkermes, Inc.$23K
- Johnson & Johnson$9K
- plus $18K from 22 others
What the payments were for
- Consulting fees$19,1846%
- Speaking & faculty fees$262,88682%
- Travel & lodging$23,5197%
- Food & beverage$14,0374%
- Education$3090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 228 | $130,122 |
| AbbVie(2 entities) | 163 | $68,789 |
| Axsome Therapeutics, Inc. | 94 | $41,635 |
| Neurocrine Biosciences, Inc. | 65 | $29,121 |
| Alkermes, Inc. | 85 | $22,675 |
| Johnson & Johnson | 39 | $9,418 |
| E.r. Squibb & Sons, L.L.C. | 32 | $8,016 |
| Vanda Pharmaceuticals Inc. | 52 | $6,598 |
| Otsuka America Pharmaceutical, Inc. | 45 | $787 |
| Supernus Pharmaceuticals, Inc. | 49 | $683 |
| Lundbeck LLC | 32 | $645 |
| Teva Pharmaceuticals USA, Inc. | 14 | $361 |
| Indivior Inc. | 18 | $238 |
| Sunovion Pharmaceuticals Inc. | 11 | $193 |
| Corium, LLC | 13 | $134 |
| Ironshore Pharmaceuticals Inc. | 7 | $124 |
| Idorsia Pharmaceuticals US Inc | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Janssen Scientific Affairs, LLC | 1 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Biogen | 2 | $38 |
| Almatica Pharma LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Neuronetics, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$319,934 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 49 | $375,832 |
| RexultiBrexpiprazole | 130 | $242,607 |
| Invega SustennaPaliperidone Palmitate | 60 | $210,852 |
| Abilify AsimtufiiAripiprazole | 27 | $156,191 |
| VraylarCariprazine Hcl | 86 | $152,060 |
| CaplytaLumateperone Tosylate | 91 | $150,698 |
| AustedoDeutetrabenazine | 12 | $143,422 |
| Invega TrinzaPaliperidone Palmitate | 13 | $120,982 |
| Abilify MaintenaAripiprazole | 29 | $82,868 |
| AuvelityDextromethorphan Hbr/Bupropion | 63 | $81,023 |
| AristadaAripiprazole Lauroxil | 24 | $77,247 |
| TrintellixVortioxetine Hydrobromide | 91 | $74,277 |
| Paliperidone ErPaliperidone | 63 | $46,651 |
| FanaptIloperidone | 12 | $42,903 |
| Risperdal ConstaRisperidone Microspheres | 24 | $31,778 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Asimtufii, Abilify Maintena | $787 | $481,666186 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $29,121 | $375,83249 claims |
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $9,418 | $363,61297 claims |
| AbbVieVraylar, Fetzima | $68,789 | $157,79498 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $130,122 | $150,69891 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $361 | $143,42212 claims |
| Axsome Therapeutics, Inc.Auvelity | $41,635 | $81,02363 claims |
| Alkermes, Inc.Aristada | $22,675 | $77,24724 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $64 | $74,27791 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $6,598 | $42,90312 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $683 | $7,71015 claims |
| Lilly USA, LLCOlanzapine | $21 | $7,175104 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Columbus
- Ruth BaileyColumbus$6K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
- Sharon ClevengerFort Wayne$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.